DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Slow-K (Potassium) - Death - Suspected Cause - Side Effect Reports

 
 



Index of reports > Death (3)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Slow-K (Potassium) death. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Slow-K side effects in male

Reported by a physician from Japan on 2012-07-18

Patient: male, weighing 38.0 kg (83.6 pounds)

Reactions: Cardio-Respiratory Arrest, Lung Neoplasm Malignant

Adverse event resulted in: death

Drug(s) suspected as cause:
Slow-K
    Administration route: Oral
    Indication: Hypokalaemia
    Start date: 2012-06-06
    End date: 2012-06-16

Bisoprolol Fumarate
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2012-06-06
    End date: 2012-06-16

Aldactone
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2012-06-06
    End date: 2012-06-16

Pimobendan
    Indication: Cardiac Failure
    Start date: 2012-06-06
    End date: 2012-06-16

Sitagliptin Phosphate
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2012-06-06
    End date: 2012-06-16

Xarelto
    Administration route: Oral
    Indication: Cerebrovascular Accident Prophylaxis
    Start date: 2012-06-06
    End date: 2012-06-15

Xarelto
    Administration route: Oral
    Indication: Atrial Fibrillation
    Start date: 2012-06-06
    End date: 2012-06-15

Lanirapid
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2012-06-06
    End date: 2012-06-16

Amiodarone Hydrochloride
    Administration route: Oral
    Indication: Arrhythmia
    Start date: 2012-06-06
    End date: 2012-06-16

Diart
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2012-06-06
    End date: 2012-06-16



Possible Slow-K side effects in male

Reported by a physician from Japan on 2012-04-16

Patient: male, weighing 72.0 kg (158.4 pounds)

Reactions: Myocardial Ischaemia

Adverse event resulted in: death

Drug(s) suspected as cause:
Slow-K
    Dosage: 600 mg, unk
    Administration route: Oral
    Start date: 2010-07-26

Warfarin Sodium
    Dosage: 2 mg, qd
    Administration route: Oral
    Indication: Thrombophlebitis
    Start date: 2011-03-01
    End date: 2011-06-01

Glyburide
    Dosage: 10 mg, qd
    Start date: 2009-06-19
    End date: 2011-04-14

Hirudoid
    Dosage: unk
    Indication: Rash
    Start date: 2011-07-14

Lidomex
    Dosage: unk
    Indication: Rash
    Start date: 2008-11-18

Riboflavin TAB
    Dosage: 60 mg, unk
    Administration route: Oral
    Indication: Rash
    Start date: 2008-11-18

Rinderon-VG
    Dosage: unk
    Indication: Rash
    Start date: 2008-11-18

Ubidecarenone
    Dosage: 30 mg, unk
    Administration route: Oral
    Indication: Oedema Peripheral
    Start date: 2008-11-18

Warfarin Sodium
    Dosage: 2 mg, unk
    Administration route: Oral
    Start date: 2011-07-14

Glyburide
    Dosage: 7.5 mg, qd
    Start date: 2009-05-15
    End date: 2009-06-18

Glyburide
    Dosage: 2.5 mg, unk
    Administration route: Oral
    Start date: 2011-07-15

Candesartan Cilexetil
    Dosage: 1.5 df, qd
    Indication: Hypertension
    Start date: 2004-01-01
    End date: 2004-03-08

Coniel
    Dosage: 4 mg, qd
    Start date: 2007-09-25
    End date: 2007-10-21

Kary UNI
    Dosage: unk
    Indication: Cataract
    Start date: 2010-11-16

Loxoprofen
    Dosage: 180 mg, unk
    Administration route: Oral
    Indication: Lumbar Spinal Stenosis
    Start date: 2008-11-18

Glyburide
    Dosage: 5 mg, qd
    Indication: Type 2 Diabetes Mellitus
    Start date: 2008-08-28
    End date: 2009-05-14

Aspirin
    Dosage: 100 mg, qd
    Indication: Carotid Arteriosclerosis
    Start date: 2004-10-12

Lasix
    Dosage: 60 mg, qd
    Administration route: Oral
    Start date: 2009-12-14
    End date: 2010-01-12

Crestor
    Dosage: 2.5 mg, unk
    Administration route: Oral
    Indication: Hyperlipidaemia
    Start date: 2008-05-26

Pydoxal
    Dosage: 90 mg, unk
    Administration route: Oral
    Start date: 2008-11-18

Limaprost
    Dosage: 15 ug, unk
    Administration route: Oral
    Indication: Osteoarthritis
    Start date: 2008-11-18

Vitalfa
    Dosage: unk
    Indication: Osteoarthritis
    Start date: 2008-11-18

Lasix
    Dosage: 40 mg, qd
    Start date: 2009-10-21
    End date: 2009-12-13

Aldecin-AQ
    Dosage: unk
    Indication: Seasonal Allergy
    Start date: 2011-09-16

Urepearl
    Dosage: unk
    Indication: Tinea Infection
    Start date: 2008-11-18

Gentamicin Sulfate
    Dosage: unk
    Indication: Rash
    Start date: 2008-11-18

Antebate
    Dosage: unk
    Indication: Rash
    Start date: 2008-11-18

Artz
    Dosage: unk
    Indication: Osteoarthritis
    Start date: 2008-11-18

Hachimijio-GAN
    Dosage: 6.0 g, unk
    Administration route: Oral
    Indication: Pollakiuria
    Start date: 2011-04-06

Glyburide
    Dosage: 5.0 mg, qd
    Start date: 2011-04-15
    End date: 2011-07-14

Candesartan Cilexetil
    Dosage: 12 mg, qd
    Start date: 2003-03-09
    End date: 2011-11-15

Coniel
    Dosage: 8 mg, qd
    Start date: 2007-10-22

Lasix
    Dosage: 80 mg, unk
    Administration route: Oral
    Start date: 2010-01-13
    End date: 2010-07-25

Lasix
    Dosage: 10 mg, qd
    Administration route: Oral
    Indication: Hypertension
    Start date: 2004-01-01
    End date: 2005-01-10

Lasix
    Dosage: 40 mg, unk
    Administration route: Oral
    Start date: 2010-07-26
    End date: 2010-09-28

Lasix
    Dosage: 40 mg, unk
    Administration route: Oral
    Start date: 2010-10-29

Mycospor
    Dosage: unk
    Indication: Tinea Infection
    Start date: 2008-11-18

Mecobalamin
    Dosage: 1500 ug, unk
    Administration route: Oral
    Indication: Osteoarthritis
    Start date: 2008-11-18

Urief
    Dosage: 8 mg, unk
    Administration route: Oral
    Indication: Pollakiuria
    Start date: 2011-04-06

Placebo
    Dosage: unk
    Administration route: Oral
    Indication: Cardiovascular Disorder
    Start date: 2008-12-15

Lasix
    Dosage: 20 mg, unk
    Administration route: Oral
    Start date: 2010-09-28
    End date: 2010-10-28

Ferrous Sulfate TAB
    Dosage: 105 mg, unk
    Administration route: Oral
    Indication: Iron Deficiency Anaemia
    Start date: 2008-11-18

Miglitol
    Dosage: 100 mg, unk
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2010-04-16

Lacmarze
    Dosage: 600 mg, unk
    Administration route: Oral
    Indication: Gastritis
    Start date: 2008-11-18

Onon
    Dosage: 450 mg, unk
    Administration route: Oral
    Indication: Rhinitis Allergic
    Start date: 2010-04-16

Candesartan Cilexetil
    Dosage: 8 mg, qd
    Administration route: Oral
    Start date: 2011-11-16

Coniel
    Dosage: 2 mg, qd
    Indication: Hypertension
    Start date: 2004-12-07
    End date: 2007-09-24

Lasix
    Dosage: 20 mg, qd
    Administration route: Oral
    Indication: Oedema Peripheral
    Start date: 2005-01-11
    End date: 2009-10-20

Olopatadine HCL
    Dosage: 10 mg, unk
    Administration route: Oral
    Indication: Rhinitis Allergic
    Start date: 2008-11-18

Other drugs received by patient: Glimicron; Nespo; Lipitor; Glimicron; Nespo; Metformin HCL; Metformin HCL; Kremezin; Metformin HCL; Glimicron



Possible Slow-K side effects in male

Reported by a physician from Japan on 2012-01-31

Patient: male, weighing 72.0 kg (158.4 pounds)

Reactions: Myocardial Ischaemia

Adverse event resulted in: death

Drug(s) suspected as cause:
Glyburide
    Dosage: 2.5 mg, unk
    Administration route: Oral
    Start date: 2011-07-15

Onon
    Dosage: 450 mg, unk
    Administration route: Oral
    Indication: Rhinitis Allergic
    Start date: 2010-04-16

Candesartan Cilexetil
    Dosage: 1.5 df, qd
    Indication: Hypertension
    Start date: 2004-01-01
    End date: 2004-03-08

Aspirin
    Dosage: 100 mg, qd
    Indication: Carotid Arteriosclerosis
    Start date: 2004-10-12

Lasix
    Dosage: 40 mg, unk
    Administration route: Oral
    Start date: 2010-07-26
    End date: 2010-09-28

Crestor
    Dosage: 2.5 mg, unk
    Administration route: Oral
    Indication: Hyperlipidaemia
    Start date: 2008-05-26

Mycospor
    Dosage: unk
    Indication: Tinea Infection
    Start date: 2008-11-18

Mecobalamin
    Dosage: 1500 ug, unk
    Administration route: Oral
    Indication: Osteoarthritis
    Start date: 2008-11-18

Limaprost
    Dosage: 15 ug, unk
    Administration route: Oral
    Indication: Osteoarthritis
    Start date: 2008-11-18

Ubidecarenone
    Dosage: 30 mg, unk
    Administration route: Oral
    Indication: Oedema Peripheral
    Start date: 2008-11-18

Artz
    Dosage: unk
    Indication: Osteoarthritis
    Start date: 2008-11-18

Placebo
    Dosage: code not broken
    Administration route: Oral
    Indication: Cardiovascular Disorder
    Start date: 2008-12-15

Slow-K
    Dosage: 600 mg, unk
    Administration route: Oral
    Indication: Hypokalaemia
    Start date: 2010-07-26

Candesartan Cilexetil
    Dosage: 8 mg, qd
    Administration route: Oral
    Start date: 2011-11-16

Coniel
    Dosage: 2 mg, qd
    Indication: Hypertension
    Start date: 2004-12-07
    End date: 2007-09-24

Coniel
    Dosage: 4 mg, qd
    Start date: 2007-09-25
    End date: 2007-10-21

Kary UNI
    Dosage: unk
    Indication: Cataract
    Start date: 2010-11-16

Glyburide
    Dosage: 10 mg, qd
    Start date: 2009-06-19
    End date: 2011-04-14

Glyburide
    Dosage: 5.0 mg, qd
    Start date: 2011-04-15
    End date: 2011-07-14

Lasix
    Dosage: 20 mg, qd
    Administration route: Oral
    Indication: Oedema Peripheral
    Start date: 2005-01-11
    End date: 2009-10-20

Lasix
    Dosage: 20 mg, unk
    Administration route: Oral
    Start date: 2010-09-28
    End date: 2010-10-28

Aldecin-AQ
    Dosage: unk
    Indication: Seasonal Allergy
    Start date: 2011-09-16

Hachimijio-GAN
    Dosage: 6.0 g, unk
    Administration route: Oral
    Indication: Pollakiuria
    Start date: 2011-04-06

Candesartan Cilexetil
    Dosage: 12 mg, qd
    Start date: 2003-03-09
    End date: 2011-11-15

Lasix
    Dosage: 10 mg, qd
    Administration route: Oral
    Indication: Hypertension
    Start date: 2004-01-01
    End date: 2005-01-10

Urief
    Dosage: 8 mg, unk
    Administration route: Oral
    Indication: Pollakiuria
    Start date: 2011-04-06

Blinded Aliskiren
    Dosage: code not broken
    Administration route: Oral
    Indication: Cardiovascular Disorder
    Start date: 2008-12-15

Loxoprofen
    Dosage: 180 mg, unk
    Administration route: Oral
    Indication: Lumbar Spinal Stenosis
    Start date: 2008-11-18

Warfarin Sodium
    Dosage: 2 mg, qd
    Administration route: Oral
    Indication: Thrombophlebitis
    Start date: 2011-03-01
    End date: 2011-06-01

Glyburide
    Dosage: 7.5 mg, qd
    Start date: 2009-05-15
    End date: 2009-06-18

Lasix
    Dosage: 80 mg, unk
    Administration route: Oral
    Start date: 2010-01-13
    End date: 2010-07-25

Lasix
    Dosage: 40 mg, unk
    Administration route: Oral
    Start date: 2010-10-29

Miglitol
    Dosage: 100 mg, unk
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2010-04-16

Pydoxal
    Dosage: 90 mg, unk
    Administration route: Oral
    Start date: 2008-11-18

Rinderon-VG
    Dosage: unk
    Indication: Rash
    Start date: 2008-11-18

Lacmarze
    Dosage: 600 mg, unk
    Administration route: Oral
    Indication: Gastritis
    Start date: 2008-11-18

Gentamicin Sulfate
    Dosage: unk
    Indication: Rash
    Start date: 2008-11-18

Warfarin Sodium
    Dosage: 2 mg, unk
    Administration route: Oral
    Start date: 2011-07-14

Urepearl
    Dosage: unk
    Indication: Tinea Infection
    Start date: 2008-11-18

Vitalfa
    Dosage: unk
    Indication: Osteoarthritis
    Start date: 2008-11-18

Blinded NO Treatment Received
    Dosage: code not broken
    Administration route: Oral
    Indication: Cardiovascular Disorder
    Start date: 2008-12-15

Coniel
    Dosage: 8 mg, qd
    Start date: 2007-10-22

Ferrous Sulfate TAB
    Dosage: 105 mg, unk
    Administration route: Oral
    Indication: Iron Deficiency Anaemia
    Start date: 2008-11-18

Riboflavin TAB
    Dosage: 60 mg, unk
    Administration route: Oral
    Indication: Rash
    Start date: 2008-11-18

Olopatadine HCL
    Dosage: 10 mg, unk
    Administration route: Oral
    Indication: Rhinitis Allergic
    Start date: 2008-11-18

Antebate
    Dosage: unk
    Indication: Rash
    Start date: 2008-11-18

Glyburide
    Dosage: 5 mg, qd
    Indication: Type 2 Diabetes Mellitus
    Start date: 2008-08-28
    End date: 2009-05-14

Lasix
    Dosage: 40 mg, qd
    Start date: 2009-10-21
    End date: 2009-12-13

Lasix
    Dosage: 60 mg, qd
    Administration route: Oral
    Start date: 2009-12-14
    End date: 2010-01-12

Hirudoid
    Dosage: unk
    Indication: Rash
    Start date: 2011-07-14

Lidomex
    Dosage: unk
    Indication: Rash
    Start date: 2008-11-18

Other drugs received by patient: Glimicron; Metformin HCL; Nespo; Metformin HCL; Lipitor; Glimicron; Glimicron; Metformin HCL; Nespo; Kremezin

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017